NT5E and neoplasm: The bulk of extracellular ADO is generated from eATP thanks to sequential hydrolysis of CD39 and CD73 [17]. ADO binds to its receptors (A1, A2A, A2B, and A3) presented on immune cells and tumor cells, regulating tumor progression and multiple immune responses, including tumor immunity [53].